BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35331424)

  • 21. Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome.
    Chen GX; Barajas-Martínez H; Ciconte G; Wu CI; Monasky MM; Xia H; Li B; Capra JA; Guo K; Zhang ZH; Chen X; Yang B; Jiang H; Tse G; Mak CM; Aizawa Y; Gollob MH; Antzelevitch C; Wilde AAM; Pappone C; Hu D
    EBioMedicine; 2023 Jan; 87():104388. PubMed ID: 36516610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
    Ishikawa T; Kimoto H; Mishima H; Yamagata K; Ogata S; Aizawa Y; Hayashi K; Morita H; Nakajima T; Nakano Y; Nagase S; Murakoshi N; Kowase S; Ohkubo K; Aiba T; Morimoto S; Ohno S; Kamakura S; Nogami A; Takagi M; Karakachoff M; Dina C; Schott JJ; Yoshiura KI; Horie M; Shimizu W; Nishimura K; Kusano K; Makita N
    Eur Heart J; 2021 Jul; 42(29):2854-2863. PubMed ID: 34219138
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Wijeyeratne YD; Tanck MW; Mizusawa Y; Batchvarov V; Barc J; Crotti L; Bos JM; Tester DJ; Muir A; Veltmann C; Ohno S; Page SP; Galvin J; Tadros R; Muggenthaler M; Raju H; Denjoy I; Schott JJ; Gourraud JB; Skoric-Milosavljevic D; Nannenberg EA; Redon R; Papadakis M; Kyndt F; Dagradi F; Castelletti S; Torchio M; Meitinger T; Lichtner P; Ishikawa T; Wilde AAM; Takahashi K; Sharma S; Roden DM; Borggrefe MM; McKeown PP; Shimizu W; Horie M; Makita N; Aiba T; Ackerman MJ; Schwartz PJ; Probst V; Bezzina CR; Behr ER
    Circ Genom Precis Med; 2020 Dec; 13(6):e002911. PubMed ID: 33164571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unravelling Novel
    Frosio A; Micaglio E; Polsinelli I; Calamaio S; Melgari D; Prevostini R; Ghiroldi A; Binda A; Carrera P; Villa M; Mastrocinque F; Presi S; Salerno R; Boccellino A; Anastasia L; Ciconte G; Ricagno S; Pappone C; Rivolta I
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel
    Monasky MM; Micaglio E; Ciconte G; Rivolta I; Borrelli V; Ghiroldi A; D'Imperio S; Binda A; Melgari D; Benedetti S; Mitrovic P; Anastasia L; Mecarocci V; Ćalović Ž; Casari G; Pappone C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gain-of-function KCNH2 mutations in patients with Brugada syndrome.
    Wang QI; Ohno S; Ding WG; Fukuyama M; Miyamoto A; Itoh H; Makiyama T; Wu J; Bai J; Hasegawa K; Shinohara T; Takahashi N; Shimizu A; Matsuura H; Horie M
    J Cardiovasc Electrophysiol; 2014 May; 25(5):522-530. PubMed ID: 24400717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel
    Micaglio E; Monasky MM; Resta N; Bagnulo R; Ciconte G; Giannelli L; Locati ET; Vicedomini G; Borrelli V; Ghiroldi A; Anastasia L; Benedetti S; Di Resta C; Ferrari M; Pappone C
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome.
    Nakajima T; Dharmawan T; Kawabata-Iwakawa R; Tamura S; Hasegawa H; Kobari T; Ota M; Tange S; Nishiyama M; Kaneko Y; Kurabayashi M
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12828. PubMed ID: 33463855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dominant negative effects of SCN5A missense variants.
    O'Neill MJ; Muhammad A; Li B; Wada Y; Hall L; Solus JF; Short L; Roden DM; Glazer AM
    Genet Med; 2022 Jun; 24(6):1238-1248. PubMed ID: 35305865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-cell transcriptomics trajectory and molecular convergence of clinically relevant mutations in Brugada syndrome.
    Tambi R; Abdel Hameid R; Bankapur A; Nassir N; Begum G; Alsheikh-Ali A; Uddin M; Berdiev BK
    Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H1935-H1948. PubMed ID: 33797273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SCN5A mutation status increases the risk of major arrhythmic events in Asian populations with Brugada syndrome: systematic review and meta-analysis.
    Rattanawong P; Chenbhanich J; Mekraksakit P; Vutthikraivit W; Chongsathidkiet P; Limpruttidham N; Prasitlumkum N; Chung EH
    Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12589. PubMed ID: 30126015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic interpretation and clinical translation of minor genes related to Brugada syndrome.
    Campuzano O; Sarquella-Brugada G; Fernandez-Falgueras A; Cesar S; Coll M; Mates J; Arbelo E; Perez-Serra A; Del Olmo B; Jordá P; Fiol V; Iglesias A; Puigmulé M; Lopez L; Pico F; Brugada J; Brugada R
    Hum Mutat; 2019 Jun; 40(6):749-764. PubMed ID: 30821013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel SCN5A variants identified in a group of Iranian Brugada syndrome patients.
    Ghaffari T; Mirhosseini Motlagh N; Daraei A; Tafrihi M; Saravi M; Sabour D
    Funct Integr Genomics; 2021 Jul; 21(3-4):331-340. PubMed ID: 33641026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.
    Hoshi M; Du XX; Shinlapawittayatorn K; Liu H; Chai S; Wan X; Ficker E; Deschênes I
    Circ Cardiovasc Genet; 2014 Apr; 7(2):123-31. PubMed ID: 24573164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H558R, a common SCN5A polymorphism, modifies the clinical phenotype of Brugada syndrome by modulating DNA methylation of SCN5A promoters.
    Matsumura H; Nakano Y; Ochi H; Onohara Y; Sairaku A; Tokuyama T; Tomomori S; Motoda C; Amioka M; Hironobe N; Toshishige M; Takahashi S; Imai K; Sueda T; Chayama K; Kihara Y
    J Biomed Sci; 2017 Dec; 24(1):91. PubMed ID: 29202755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SCN5A compound heterozygosity mutation in Brugada syndrome: Functional consequences and the implication for pharmacological treatment.
    Joviano-Santos JV; Santos-Miranda A; Neri EA; Fonseca-Alaniz MH; Krieger JE; Pereira AC; Roman-Campos D
    Life Sci; 2021 Aug; 278():119646. PubMed ID: 34048814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brugada Syndrome: From Molecular Mechanisms and Genetics to Risk Stratification.
    Popa IP; Șerban DN; Mărănducă MA; Șerban IL; Tamba BI; Tudorancea I
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinic and genetic polymorphism of Brugada syndrome in Russian patients, caused by mutation in SCN5A gene].
    Zakliaz'minskaia EV; Shestak AG; Revishvili ASh; Pronicheva IV; Podoliak DG; Nechaenko MA; Poliakov AV; Dzemeshkevich SL
    Khirurgiia (Mosk); 2013; (2):49-53. PubMed ID: 23503384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel
    Monasky MM; Micaglio E; Ciconte G; Borrelli V; Giannelli L; Vicedomini G; Ghiroldi A; Anastasia L; Locati ET; Benedetti S; Di Resta C; Casari G; Pappone C
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants.
    Monasky MM; Micaglio E; Vicedomini G; Locati ET; Ciconte G; Giannelli L; Giordano F; Crisà S; Vecchi M; Borrelli V; Ghiroldi A; D'Imperio S; Di Resta C; Benedetti S; Ferrari M; Santinelli V; Anastasia L; Pappone C
    Europace; 2019 Oct; 21(10):1550-1558. PubMed ID: 31292628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.